Cosmos Health Inc. (NASDAQ:COSM – Get Free Report) CEO Grigorios Siokas acquired 62,500 shares of the stock in a transaction that occurred on Wednesday, January 15th. The shares were bought at an average cost of $0.80 per share, for a total transaction of $50,000.00. Following the completion of the transaction, the chief executive officer now directly owns 4,087,727 shares of the company’s stock, valued at $3,270,181.60. This represents a 1.55 % increase in their position. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink.
Grigorios Siokas also recently made the following trade(s):
- On Monday, January 13th, Grigorios Siokas acquired 163,666 shares of Cosmos Health stock. The shares were bought at an average cost of $0.61 per share, for a total transaction of $99,836.26.
- On Friday, December 20th, Grigorios Siokas bought 257,334 shares of Cosmos Health stock. The stock was purchased at an average price of $0.58 per share, for a total transaction of $149,253.72.
Cosmos Health Stock Performance
Shares of NASDAQ:COSM traded up $0.03 during midday trading on Thursday, hitting $0.83. The company’s stock had a trading volume of 594,649 shares, compared to its average volume of 358,919. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.24 and a current ratio of 1.44. The stock’s 50 day simple moving average is $0.71 and its 200 day simple moving average is $0.91. The stock has a market capitalization of $19.31 million, a price-to-earnings ratio of -0.34 and a beta of 5.57. Cosmos Health Inc. has a fifty-two week low of $0.47 and a fifty-two week high of $1.58.
About Cosmos Health
Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.
Further Reading
- Five stocks we like better than Cosmos Health
- The 3 Best Blue-Chip Stocks to Buy Now
- UnitedHealth Group Pulls Back Into Another Healthy Opportunity
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Micron Technology: Riding the AI Wave to Long-Term Growth
- 3 Ways To Invest In Coffee, Other Than Drinking It
- 3 Cheap Small-Cap Banks for Dividend Growth Investors
Receive News & Ratings for Cosmos Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cosmos Health and related companies with MarketBeat.com's FREE daily email newsletter.